CT, if taken orally, can repress NHE1 expression, inhibit cardiomyocyte hypertrophy, reduce glycogen storage, and alleviate the fatty degeneration and fibrosis of cardiomyocytes to improve the cardiac functions of DCM rats obviously. The gene discussed is SLC9A1; the disease is familial dilated cardiomyopathy.